The DOI matches its Crossref record; 318 of the 318 references it cites were found in a registry or an index.
Deubiquitinase inhibition as a cancer therapeutic strategy
Open accessAbstract
The ubiquitin proteasome system (UPS) is the main system for controlled protein degradation and a key regulator of fundamental cellular processes. The dependency of cancer cells on a functioning UPS has made this an attractive target for development of drugs that show selectivity for tumor cells. Deubiquitinases (DUBs, ubiquitin isopeptidases) are components of the UPS that catalyze the removal of ubiquitin moieties from target proteins or polyubiquitin chains, resulting in altered signaling or changes in protein stability. A number of DUBs regulate processes associated with cell proliferation and apoptosis, and as such represent candidate targets for cancer therapeutics. The majority of DUBs are cysteine proteases and are likely to be more "druggable" than E3 ligases. Cysteine residues in the active sites of DUBs are expected to be reactive to various electrophiles. Various compounds containing α,β-unsaturated ketones have indeed been demonstrated to inhibit cellular DUB activity. Inhibition of proteasomal cysteine DUB enzymes (i.e. USP14 and UCHL5) can be predicted to be particularly cytotoxic to cancer cells as it leads to blocking of proteasome function and accumulation of proteasomal substrates. We here provide an overall review of DUBs relevant to cancer and of various small molecules which have been demonstrated to inhibit DUB activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–318 of 318
An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels
Diamonti, A. J., Guy, P. M., Ivanof, C., Wong, K., Sweeney, C. A., & Carraway, K. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052709799 · Cited by 144
Stabilization of the E3 Ubiquitin Ligase Nrdp1 by the Deubiquitinating Enzyme USP8
Wu, X., Yen, L., Irwin, L., Sweeney, C., & Carraway, K. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7748-7757.2004 · Cited by 144
The Comparative Proteomics of Ubiquitination in MousePreprint
Semple, C. A. M., RIKEN GER Group, & Members, G. (2003) · Genome Research · doi:10.1101/gr.980303 · Cited by 142
Liu, J., Chung, H., Vogt, M., Jin, Y., Malide, D., He, L., Dundr, M., & Levens, D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.11 · Cited by 141
Curcio‐Morelli, C., Zavacki, A. M., Christoffolete, M. A., Gereben, B., Freitas, B. C. G., Harney, J. W., Li, Z., Wu, G., & Bianco, A. C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18348 · Cited by 141
UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-ubiquitination Promotes EGFR Degradation
Alwan, H. A. J., & van Leeuwen, J. E. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m604711200 · Cited by 140
van Kasteren, P. B., Beugeling, C., Ninaber, D. K., Frias‐Staheli, N., van Boheemen, S., García‐Sastre, A., Snijder, E. J., & Kikkert, M. (2011) · Journal of Virology · doi:10.1128/jvi.06277-11 · Cited by 140
Urbé, S., Liu, H., Hayes, S., Heride, C., Rigden, D. J., & Clague, M. J. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-08-0668 · Cited by 138
The tumor suppressor CYLD regulates entry into mitosis
Stegmeier, F. P., Sowa, M. E., Nalepa, G., Gygi, S. P., Harper, J. W., & Elledge, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703268104 · Cited by 137
Narumiya, S., & Fukushima, M. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23605-9 · Cited by 136
Draker, R., Sarcinella, E., & Cheung, P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1352 · Cited by 135
Characterization of ubiquitin and ubiquitin‐like‐protein isopeptidase activities
Nicholson, B., Leach, C. A., Goldenberg, S. J., Francis, D. M., Kodrasov, M. P., Tian, X., Shanks, J. R., Sterner, D. E., Bernal, A., Mattern, M. R., et al. (2008) · Protein Science · doi:10.1110/ps.083450408 · Cited by 135
Suzuki, M., Mori, M., Niwa, T., Hirata, R., Furuta, K., Ishikawa, T., & Noyori, R. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9628359 · Cited by 131
Regulation of Histone H2A and H2B Deubiquitination and Xenopus Development by USP12 and USP46
Joo, H.-Y., Jones, A., Yang, C., Zhai, L., Smith, A. D., Zhang, Z., Chandrasekharan, M. B., Sun, Z., Renfrow, M. B., Wang, Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158311 · Cited by 131
Mullally, J. E., Moos, P. J., Edes, K., & Fitzpatrick, F. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102198200 · Cited by 129
The USP1/UAF1 Complex Promotes Double-Strand Break Repair through Homologous Recombination
Murai, J., Yang, K., Dejsuphong, D., Hirota, K., Takeda, S., & D’Andrea, A. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05058-11 · Cited by 128
Li, J., Tan, Q., Yan, M., Liu, L., Lin, H., Zhao, F., Bao, G., Kong, H., Ge, C., Zhang, F., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-166 · Cited by 126
USP11 augments TGFβ signalling by deubiquitylating ALK5
Al-Salihi, M. A., Herhaus, L., Macartney, T., & Sapkota, G. P. (2012) · Open Biology · doi:10.1098/rsob.120063 · Cited by 126
Chen, P.-C., Qin, L., Li, X.-M., Walters, B. J., Wilson, J. A., Mei, L., & Wilson, S. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2635-09.2009 · Cited by 124
Parsons, J. L., Dianova, I. I., Khoronenkova, S. V., Edelmann, M. J., Kessler, B. M., & Dianov, G. L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.016 · Cited by 121
Assembly and Function of the Proteasome
Saeki, Y., & Tanaka, K. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-474-2_22 · Cited by 120
Regulation of p53 stability and function by the deubiquitinating enzyme USP42
Hock, A. K., Vigneron, A. M., Carter, S., Ludwig, R. L., & Vousden, K. H. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.419 · Cited by 120
Cao, Z., Wu, X., Yen, L., Sweeney, C., & Carraway, K. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01245-06 · Cited by 119
Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum
Cross, B. C. S., McKibbin, C., Callan, A. C., Roboti, P., Piacenti, M., Rabu, C., Wilson, C. M., Whitehead, R. C., Flitsch, S. L., Pool, M., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.054494 · Cited by 114
Colombo, M., Vallese, S., Peretto, I., Jacq, X., Rain, J., Colland, F., & Guedat, P. (2010) · ChemMedChem · doi:10.1002/cmdc.200900409 · Cited by 113
Identification of New Compounds That Trigger Apoptosome-Independent Caspase Activation and Apoptosis
Aleo, E., Henderson, C. J., Fontanini, A., Solazzo, B., & Brancolini, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0702 · Cited by 112
The role of deubiquitinating enzymes in apoptosis
Ramakrishna, S., Suresh, B., & Baek, K. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0504-6 · Cited by 110
Couch, R. D., Browning, R. G., Honda, T., Gribble, G. W., Wright, D. L., Sporn, M. B., & Anderson, A. C. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.031 · Cited by 110
Carolan, B. J., Heguy, A., Harvey, B., Leopold, P. L., Ferris, B., & Crystal, R. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2224 · Cited by 109
Edelmann, M. J., Nicholson, B., & Kessler, B. M. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002031 · Cited by 109
Šimíček, M., Lievens, S., Laga, M., Guzenko, D., Aushev, V. N., Kalev, P., Baietti, M. F., Strelkov, S. V., Gevaert, K., Tavernier, J. H., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2847 · Cited by 107
Mullally, J. E., & Fitzpatrick, F. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.351 · Cited by 106
Fiebiger, E., Hirsch, C., Vyas, J. M., Gordon, E. J., Ploegh, H. L., & Tortorella, D. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-07-0506 · Cited by 104
Stanišić, V., Malovannaya, A., Qin, J., Lonard, D. M., & O’Malley, B. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007484 · Cited by 101
Yuasa‐Kawada, J., Kinoshita-Kawada, M., Rao, Y., & Wu, J. Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801262106 · Cited by 101
MdmX is a substrate for the deubiquitinating enzyme USP2a
Allende-Vega, N., Sparks, A., Lane, D. P., & Saville, M. K. (2010) · Oncogene · doi:10.1038/onc.2009.330 · Cited by 100
USP11 negatively regulates TNFα-induced NF-κB activation by targeting on IκBα
Sun, W., Tan, X., Shi, Y., Xu, G., Mao, R., Gu, X. F., Fan, Y., Yu, Y., Burlingame, S. M., Zhang, H., et al. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.10.008 · Cited by 100
A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells
Vendrell, J. A., Ghayad, S. E., Larbi, S. B., Dumontet, C., Mechti, N., & Cohen, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210269 · Cited by 100
Zhang, F., Wu, Z., Zhang, P., Tian, G., Finley, D. J., & Shi, Y. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.022 · Cited by 99
Yu, L., Adegoke, O. A. J., Nepveu, A., Nakayama, K. I., Bedard, N., Cheng, D., Peng, J., & Wing, S. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00329-08 · Cited by 99
The USP19 Deubiquitinase Regulates the Stability of c-IAP1 and c-IAP2
Mei, Y., Alcivar, A., Hu, S., & Yang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282020 · Cited by 98
Integral UBL domain proteins: a family of proteasome interacting proteins
Hartmann‐Petersen, R., & Gordon, C. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.006 · Cited by 95
Kim, J., Kim, W., Liu, Z., Loda, M. F., & Freeman, M. R. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19550 · Cited by 93
Ubiquitin-specific Protease 19 (USP19) Regulates Hypoxia-inducible Factor 1α (HIF-1α) during Hypoxia
Altun, M., Zhao, B., Velasco, K., Liu, H., Hassink, G. C., Paschke, J., Pereira, T., & Lindsten, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.305615 · Cited by 91
Mermerian, A. H., Case, A. W., Stein, R. L., & Cuny, G. D. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.027 · Cited by 90
Cai, S., Babbitt, R. W., & Marchesi, V. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2828 · Cited by 89
Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia
Dumitriu, B., Feng, X., Townsley, D. M., Ueda, Y., Yoshizato, T., Calado, R. T., Yang, Y., Wakabayashi, Y., Kajigaya, S., Ogawa, S., et al. (2014) · Blood · doi:10.1182/blood-2014-10-607572 · Cited by 88
BRCC36 Is Essential for Ionizing Radiation–Induced BRCA1 Phosphorylation and Nuclear Foci Formation
Chen, X., Arciero, C. A., Wang, C., Broccoli, D., & Godwin, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4194 · Cited by 87
Alkylation Damage by Lipid Electrophiles Targets Functional Protein Systems
Codreanu, S. G., Cantu, J. C., Zhu, J., Tallman, K. A., Beavers, W. N., Porter, N. A., Marnett, L. J., Zhang, B., & Liebler, D. C. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.032953 · Cited by 87
Reiner, T., Parrondo, R. D., Pozas, A. D. L., Palenzuela, D. L., & Perez‐Stable, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056234 · Cited by 86
Wang, H., Ying, Z., & Wang, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299990 · Cited by 86
The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells
Sacco, J. J., Yau, T. Y., Darling, S., Patel, V., Liu, H., Urbé, S., Clague, M. J., & Coulson, J. M. (2013) · Oncogene · doi:10.1038/onc.2013.512 · Cited by 86
Proteasome inhibitors stimulate activator protein‐1 pathway via reactive oxygen species production
Wu, H., Chi, K., & Lin, W. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03151-4 · Cited by 85
USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination
Martín, Y., Cabrera, E., Amoedo, H., Hernández-Pérez, S., Domínguez-Kelly, R., & Freire, R. (2014) · Oncogene · doi:10.1038/onc.2014.38 · Cited by 84
Aldini, G., Dalle‐Donne, I., Colombo, R., Facino, R. M., Milzani, A., & Carini, M. (2006) · ChemMedChem · doi:10.1002/cmdc.200600075 · Cited by 84
Issaenko, O. A., & Amerik, A. Y. (2012) · Cell Cycle · doi:10.4161/cc.20174 · Cited by 83
Kim, J., Noskov, V. N., Lu, X., Bergmann, A., Ren, X., Warth, T., Richardson, P., Kouprina, N., & Stubbs, L. J. (2000) · Genome Research · doi:10.1101/gr.10.8.1138 · Cited by 82
Koharudin, L. M. I., Liu, H., Maio, R. D., Kodali, R. B., Graham, S. H., & Gronenborn, A. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002295107 · Cited by 80
Paulsson, K. M., Békássy, A. N., Olofsson, T., Mitelman, F., Johansson, B., & Panagopoulos, I. (2005) · Leukemia · doi:10.1038/sj.leu.2404076 · Cited by 79
USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity
Burrows, J. F., Kelvin, A. A., McFarlane, C., Burden, R. E., McGrattan, M. J., de la Vega, M., Govender, U., Quinn, D. J., Dib, K., Gadina, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807216200 · Cited by 78
The ubiquitin-specific protease USP47 is a novel β-TRCP interactor regulating cell survival
Peschiaroli, A., Skaar, J. R., Pagano, M., & Melino, G. (2009) · Oncogene · doi:10.1038/onc.2009.430 · Cited by 78
Rinaldi, T., Ricci, P. C., Porro, D., Bolotin‐Fukuhara, M., & Frontali, L. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.10.2917 · Cited by 77
Aldini, G., Carini, M., Vistoli, G., Shibata, T., Kusano, Y., Gamberoni, L., Dalle‐Donne, I., Milzani, A., & Uchida, K. (2007) · Biochemistry · doi:10.1021/bi0618565 · Cited by 77
Li, Z., Melandri, F. D., Berdo, I., Jansen, M., Hunter, L., Wright, S., Valbrun, D., & Figueiredo‐Pereira, M. E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.098 · Cited by 77
Brnjic, S., Mazurkiewicz, M., Fryknäs, M., Sun, C., Zhang, X., Larsson, R. L., D’Arcy, P., & Linder, S. T. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5322 · Cited by 76
Self-citationTian, X., Isamiddinova, N. S., Peroutka, R. J., Goldenberg, S. J., Mattern, M. R., Nicholson, B., & Leach, C. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2010.0317 · Cited by 76
Verbitski, S. M., Mullally, J. E., Fitzpatrick, F. A., & Ireland, C. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030448l · Cited by 75
The ubiquitin specific protease USP34 promotes ubiquitin signaling at DNA double-strand breaks
Sy, S. M.-H., Jiang, J., O, W. S., Deng, Y., & Huen, M. S. Y. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt622 · Cited by 75
Ubiquitin-specific Cysteine Protease 2a (USP2a) Regulates the Stability of Aurora-A
Shi, Y., Solomon, L. R., Pereda‐Lopez, A., Giranda, V. L., Luo, Y., Johnson, E. F., Shoemaker, A. R., Leverson, J. D., & Liu, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231498 · Cited by 75
Panner, A., Crane, C. A., Weng, C., Feletti, A., Fang, S., Parsa, A. T., & Pieper, R. O. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3979 · Cited by 75
Lundgren, J., Masson, P., Realini, C. A., & Young, P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5320-5330.2003 · Cited by 75
The JAMM motif of human deubiquitinase Poh1 is essential for cell viability
Gallery, M. A., Blank, J. L., Lin, Y., Gutierrez, J. A., Pulido, J. C., Rappoli, D. M., Badola, S., Rolfe, M., & MacBeth, K. J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0542 · Cited by 75
Chen, J., Gu, H.-Y., Lu, N., Yang, Y., Liu, W., Qi, Q., Rong, J., Wang, X.-T., You, Q., & Guo, Q. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.05.003 · Cited by 73
Self-citationWang, X., Stafford, W. C., Mazurkiewicz, M., Fryknäs, M., Brjnic, S., Zhang, X., Gullbo, J., Larsson, R. L., Arnér, E. S. J., D’Arcy, P., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.091322 · Cited by 73
Self-citationTargeting Deubiquitinases Enabled by Chemical Synthesis of Proteins
Ohayon, S., Spasser, L., Aharoni, A., & Brik, A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2116712 · Cited by 72
Mazumdar, T., Gorgun, F. M., Sha, Y., Tyryshkin, A., Zeng, S., Hartmann‐Petersen, R., Jørgensen, J. P., Hendil, K. B., & Eissa, N. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913495107 · Cited by 71
Zhang, Y., van Deursen, J., & Galardy, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023389 · Cited by 71
Ubiquitin-Specific Protease 25 Functions in Endoplasmic Reticulum-Associated Degradation
Blount, J. R., Burr, A. A., Denuc, A., Marfany, G., & Todi, S. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036542 · Cited by 70
The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling
Chen, R., Zhang, L., Zhong, B., Tan, B., Liu, Y., & Shu, H. (2010) · Cell Research · doi:10.1038/cr.2010.41 · Cited by 70
Ubiquitin-Specific Proteases 25 Negatively Regulates Virus-Induced Type I Interferon Signaling
Zhong, H., Wang, D., Fang, L., Zhang, H., Luo, R., Shang, M., Ouyang, C., Ouyang, H., Chen, H., & Xiao, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080976 · Cited by 69
Molecular Cloning and Expression of a 26 S Protease Subunit Enriched in Dileucine Repeats
Deveraux, Q. L., Jensen, C., & Rechsteiner, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23726 · Cited by 68
Renedo, M., Gayarre, J., García-Domínguez, C. A., Pérez-Rodríguez, A., Prieto, A., Cañada, F. J., Rojas, J. M., & Pérez‐Sala, D. (2007) · Biochemistry · doi:10.1021/bi602389p · Cited by 66
Moretti, J., Chastagner, P., Liang, C., Cohn, M. A., Israël, A., & Brou, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366807 · Cited by 66
Zhou, B., Zuo, Y., Li, B., Wang, H., Liu, H., Wang, X., Qiu, X., Hu, Y., Wen, S., Du, J., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1057 · Cited by 66
Self-citationIdentification of a 26S Proteasome-Associated UCH in Fission Yeast
Li, T., Naqvi, N. I., Yang, H., & Teo, T. S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2767 · Cited by 64
Liu, H., Li, W., Ahmad, M., Miller, T. M., Rose, M. E., Poloyac, S. M., Uechi, G. T., Balasubramani, M., Hickey, R. W., & Graham, S. H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.020 · Cited by 64
Dong, G., Chanudet, E., Zeng, N., Appert, A., Chen, Y.-W., Au, W.-Y., Hamoudi, R., Watkins, J. A., Ye, H., Liu, H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1859 · Cited by 64
Fannemel, M., Barøy, T., Holmgren, A., Rødningen, O. K., Haugsand, T. M., Hansen, B., Frengen, E., & Misceo, D. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.05.008 · Cited by 63
Adrm1, a Putative Cell Adhesion Regulating Protein, is a Novel Proteasome-associated Factor
Jørgensen, J. P., Lauridsen, A.-M. B., Kristensen, P., Dissing, K., Johnsen, A. H., Hendil, K. B., & Hartmann‐Petersen, R. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.011 · Cited by 62
Functional Asymmetries of Proteasome Translocase Pore
Erales, J., Hoyt, M. A., Troll, F., & Coffino, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357327 · Cited by 60
Guo, Y., Dolinko, A. V., Chinyengetere, F., Stanton, B. A., Bomberger, J. M., Demidenko, E., Zhou, D.-C., Gallagher, R. E., Ma, T., Galimberti, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1100 · Cited by 60
Buus, R., Faronato, M., Hammond, D. E., Urbé, S., & Clague, M. J. (2009) · Current Biology · doi:10.1016/j.cub.2009.07.040 · Cited by 59
OTUD5 Regulates p53 Stability by Deubiquitinating p53
Luo, J., Lu, Z., Lu, X., Chen, L., Cao, J., Zhang, S., Yang, L., & Zhou, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077682 · Cited by 57
The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover
Bohgaki, M., Hakem, A., Halaby, M. J., Bohgaki, T., Li, Q., Bissey, P.-A., Shloush, J., Kislinger, T., Sanchez, O., Sheng, Y., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.7 · Cited by 56
Li, Y., Sun, X., Elferich, J., Shinde, U. P., David, L. L., & Dai, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533109 · Cited by 54
Pham, L. V., Tamayo, A. T., Li, C., Bornmann, W. G., Priebe, W., & Ford, R. J. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0238 · Cited by 53
Structural modeling of ataxin‐3 reveals distant homology to adaptins
Albrecht, M., Hoffmann, D. E., Evert, B. O., Schmitt, I., Wüllner, U., & Lengauer, T. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10280 · Cited by 53
Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy
Allende-Vega, N., & Saville, M. K. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.004 · Cited by 52
Buchhagen, D. L., Qiu, L., & Etkind, P. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570406 · Cited by 51
Aressy, B., Jullien, D., Cazalès, M., Marcellin, M., Bugler, B., Burlet‐Schiltz, O., & Ducommun, B. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13133 · Cited by 48
Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin‐proteasome system
Berndtsson, M., Beaujouin, M., Rickardson, L., Havelka, A. M., Larsson, R. L., Westman, J., Liaudet‐Coopman, E., & Linder, S. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.24004 · Cited by 45
Self-citationWang, Z., Aris, V. M., Ogburn, K. D., Soteropoulos, P., & Figueiredo‐Pereira, M. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601201200 · Cited by 42
Endoplasmic reticulum stress contributes to the cell death induced by UCH-L1 inhibitor
Tan, Y.-Y., Zhou, H.-Y., Wang, Z., & Chen, S.-D. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9862-x · Cited by 41
Carneiro, A. P., Reis, C. F., Morari, E. C., Maia, Y. C. D. P., Nascimento, R., Bonatto, J. M. C., de Souza, M. A., Goulart, L. R., & Ward, L. S. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.331 · Cited by 40
Fontanini, A., Foti, C., Potu, H., Crivellato, E., Maestro, R., Bernardi, P., Demarchi, F., & Brancolini, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806113200 · Cited by 39
Eeyarestatin 1 Interferes with Both Retrograde and Anterograde Intracellular Trafficking Pathways
Aletrari, M.-O., McKibbin, C., Williams, H. M., Pawar, V. S., Pietroni, P., Lord, J. M., Flitsch, S. L., Whitehead, R. C., Swanton, E., High, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022713 · Cited by 37
Shotgun proteomics and network analysis of neuroblastoma cell lines treated with curcumin
D’Aguanno, S., D’Agnano, I., Canio, M. D., Rossi, C., Bernardini, S., Federici, G., & Urbani, A. (2012) · Molecular BioSystems · doi:10.1039/c2mb05498a · Cited by 37
miR-218 regulates focal adhesion kinase–dependent TGFβ signaling in fibroblasts
Guo, F., Carter, D. E., & Leask, A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-08-0451 · Cited by 37
Kim, D.-H., Kim, E.-H., Na, H.-K., Sun, Y., & Surh, Y.-J. (2010) · Oncogene · doi:10.1038/onc.2010.8 · Cited by 36
A Human XPC Protein Interactome—A Resource
Lubin, A., Zhang, L., Chen, H., White, V., & Gong, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms15010141 · Cited by 35
Yu, L., Bedard, N., Chevalier, S., & Wing, S. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015936 · Cited by 35
USP28 is a potential prognostic marker for bladder cancer
Guo, G., Xu, Y., Gong, M., Cao, Y. W., & An, R. (2013) · Tumor Biology · doi:10.1007/s13277-013-1525-1 · Cited by 32
De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1
Mahul‐Mellier, A., Datler, C., Pazarentzos, E., Lin, B., Chaisaklert, W., AbuAli, G., & Grimm, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.022 · Cited by 28
Isoform‐Specific Localization of the Deubiquitinase USP33 to the Golgi Apparatus
Thorne, C., Eccles, R. L., Coulson, J. M., Urbé, S., & Clague, M. J. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01261.x · Cited by 26
Silencing of the UCHL1 gene in giant cell tumors of bone
Fellenberg, J., Lehner, B., & Witte, D. (2010) · International Journal of Cancer · doi:10.1002/ijc.25205 · Cited by 25
Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase
Cholay, M., Reverdy, C., Bénarous, R., Colland, F., & Daviet, L. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.10.023 · Cited by 23
Okuda, H., Ohdan, H., Nakayama, M., Koseki, H., Nakagawa, T., & Ito, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079813 · Cited by 23
Fukutomi, S., Seki, N., Koda, K., & Miyazaki, M. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701491173 · Cited by 22
Cited by
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Liu, F., Chen, J., Li, K., Li, H., Zhu, Y., Zhai, Y., Lu, B., Fan, Y., Liu, Z., Chen, X., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02046-3 · Cited by 326
Li, D., Wang, Y., Dong, C., Chen, T., Dong, A., Ren, J., Li, W., Shu, G., Yang, J., Shen, W., et al. (2023) · Oncogene · doi:10.1038/s41388-022-02537-x · Cited by 316
Small-Molecule Modulation of Protein Homeostasis
Burslem, G. M., & Crews, C. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00077 · Cited by 283
Metadata
- Authors
- D'Arcy, P., Wang, X., & Linder, S.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 147
- Pages
- 32-54
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2139592339
- Cited by
- 310
- References
- 318
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.